Prevention of Elevation in Plasma Triacylglycerol with High-Dose Bezafibrate Treatment Abolishes Insulin Resistance and Attenuates Glucose Intolerance Induced by Short-Term Treatment with Dexamethasone in Rats.
Maiara Destro InácioAlex RafachoNathália Aparecida de Paula CamafortePoliana TeixeiraPriscilla Maria Ponce VaredaNatália Moretti ViolatoJosé Roberto BosqueiroPublished in: International journal of endocrinology (2018)
High-dose bezafibrate treatment prevents the increase in plasma triacylglycerol and the development of insulin resistance and attenuates glucose intolerance in rats caused by GC treatment, indicating the involvement of dyslipidemia in the GC-induced insulin resistance.